FOCALFLEX (CE Mark) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT06271967

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06271967
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06271967. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-15 (actual); primary completion 2025-07-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FOCALFLEX (CE Mark) Study
Condition
Atrial Fibrillation Paroxysmal
Intervention (Device)
TactiFlex™ Ablation Catheter Sensor Enabled™
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06271967
Content hash
215bcca6d9cee50af979a31bb6024fec43d5dfd5964e96fca3938a2c549cf475